Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) completed the full study following the initial Probudur pilot study performed by the U.S. Army Institute of Surgical Research (USAISR) under an existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results